These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26198342)

  • 1. HIV pre-exposure prophylaxis and health and community systems in the Global South: Thailand case study.
    Colby D; Srithanaviboonchai K; Vanichseni S; Ongwandee S; Phanuphak N; Martin M; Choopanya K; Chariyalertsak S; van Griensven F
    J Int AIDS Soc; 2015; 18(4 Suppl 3):19953. PubMed ID: 26198342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a pre-exposure prophylaxis programme for men who have sex with men and transgender women in Thailand: learning through the HIV prevention cascade lens.
    Ramautarsing RA; Meksena R; Sungsing T; Chinbunchorn T; Sangprasert T; Fungfoosri O; Meekrua D; Sumalu S; Pasansai T; Bunainso W; Wongsri T; Mainoy N; Colby D; Avery M; Mills S; Vannakit R; Phanuphak P; Phanuphak N
    J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25540. PubMed ID: 32602660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-exposure prophylaxis for men and transgender women who have sex with men in Brazil: opportunities and challenges.
    Veloso VG; Mesquita F; Grinsztejn B
    J Int AIDS Soc; 2015; 18(4 Suppl 3):20010. PubMed ID: 26198347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diverse contexts and social factors among young cisgender men and transgender women who sell or trade sex in Bangkok and Pattaya, Thailand: formative research for a PrEP program implementation study.
    Truong JM; Chemnasiri T; Wirtz AL; Mon SHH; Varangrat A; Decker M; Janyam S; Linjongrat D; Sirivongrangson P; Hickey AC; Weir BW; Beyrer C;
    AIDS Care; 2022 Nov; 34(11):1443-1451. PubMed ID: 35473429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lived experiences with pre-exposure prophylaxis uptake and adherence among transgender women in Thailand: a qualitative study.
    Janamnuaysook R; Guo Y; Yu YJ; Phanuphak N; Kawichai S; MacDonell K; Jupimai T; Rongkavilit C; Wang B
    Sex Health; 2024 Jan; 21():. PubMed ID: 38219741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of nonadherence to key population-led HIV pre-exposure prophylaxis services among Thai men who have sex with men and transgender women.
    Seekaew P; Nguyen E; Sungsing T; Jantarapakde J; Pengnonyang S; Trachunthong D; Mingkwanrungruang P; Sirisakyot W; Phiayura P; Panpet P; Meekrua P; Praweprai N; Suwan F; Sangtong S; Brutrat P; Wongsri T; Nakorn PRN; Mills S; Avery M; Vannakit R; Phanuphak P; Phanuphak N
    BMC Public Health; 2019 Mar; 19(1):328. PubMed ID: 30898095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimising HIV pre-exposure prophylaxis and testing strategies in men who have sex with men in Australia, Thailand, and China: a modelling study and cost-effectiveness analysis.
    Zhao R; Fairley CK; Cook AR; Phanuphak N; He S; Tieosapjaroen W; Chow EPF; Phillips TR; Jin Tan RK; Wei Y; Shen M; Zhuang G; Ong JJ; Zhang L
    Lancet Glob Health; 2024 Feb; 12(2):e243-e256. PubMed ID: 38245115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of a Test, Treat, and Prevent HIV program among men who have sex with men and transgender women in Thailand, 2015-2016.
    Ongwandee S; Lertpiriyasuwat C; Khawcharoenporn T; Chetchotisak P; Thiansukhon E; Leerattanapetch N; Leungwaranan B; Manopaiboon C; Phoorisri T; Visavakum P; Jetsawang B; Poolsawat M; Nookhai S; Vasanti-Uppapokakorn M; Karuchit S; Kittinunvorakoon C; Mock P; Prybylski D; Sukkul AC; Roels T; Martin M
    PLoS One; 2018; 13(7):e0201171. PubMed ID: 30044867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost and cost-effectiveness analysis of pre-exposure prophylaxis among men who have sex with men in two hospitals in Thailand.
    Suraratdecha C; Stuart RM; Manopaiboon C; Green D; Lertpiriyasuwat C; Wilson DP; Pavaputanon P; Visavakum P; Monkongdee P; Khawcharoenporn T; Tharee P; Kittinunvorakoon C; Martin M
    J Int AIDS Soc; 2018 Jul; 21 Suppl 5(Suppl Suppl 5):e25129. PubMed ID: 30033559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Princess PrEP program: the first key population-led model to deliver pre-exposure prophylaxis to key populations by key populations in Thailand.
    Phanuphak N; Sungsing T; Jantarapakde J; Pengnonyang S; Trachunthong D; Mingkwanrungruang P; Sirisakyot W; Phiayura P; Seekaew P; Panpet P; Meekrua P; Praweprai N; Suwan F; Sangtong S; Brutrat P; Wongsri T; Na Nakorn PR; Mills S; Avery M; Vannakit R; Phanuphak P
    Sex Health; 2018 Nov; 15(6):542-555. PubMed ID: 30249317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "I wish to remain HIV negative": Pre-exposure prophylaxis adherence and persistence in transgender women and men who have sex with men in coastal Kenya.
    Kimani M; van der Elst EM; Chirro O; Wahome E; Ibrahim F; Mukuria N; de Wit TFR; Graham SM; Operario D; Sanders EJ
    PLoS One; 2021; 16(1):e0244226. PubMed ID: 33465090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceptability of pre-exposure prophylaxis among men who have sex with men and transgender women in Northern Thailand.
    Yang D; Chariyalertsak C; Wongthanee A; Kawichai S; Yotruean K; Saokhieo P; Guadamuz T; Suwanvanichkij V; Beyrer C; Chariyalertsak S
    PLoS One; 2013; 8(10):e76650. PubMed ID: 24116132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with long-term HIV pre-exposure prophylaxis engagement and adherence among transgender women in Brazil, Mexico and Peru: results from the ImPrEP study.
    Konda KA; Torres TS; Mariño G; Ramos A; Moreira RI; Leite IC; Cunha M; Jalil EM; Hoagland B; Guanira JV; Benedetti M; Pimenta C; Vermandere H; Bautista-Arredondo S; Vega-Ramirez H; Veloso VG; Caceres CF; Grinsztejn B;
    J Int AIDS Soc; 2022 Oct; 25 Suppl 5(Suppl 5):e25974. PubMed ID: 36225148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost-effectiveness of HIV pre-exposure prophylaxis in men who have sex with men and transgender women at high risk of HIV infection in Brazil.
    Luz PM; Osher B; Grinsztejn B; Maclean RL; Losina E; Stern ME; Struchiner CJ; Parker RA; Freedberg KA; Mesquita F; Walensky RP; Veloso VG; Paltiel AD
    J Int AIDS Soc; 2018 Mar; 21(3):e25096. PubMed ID: 29603888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prepped for PrEP? Acceptability, continuation and adherence among men who have sex with men and transgender women enrolled as part of Vietnam's first pre-exposure prophylaxis program.
    Green KE; Nguyen LH; Phan HTT; Vu BN; Tran MH; Ngo HV; Tieu VTT; Van H; Le TM; Do KQ; Nguyen PA; Ngo TM; Doan AH; Bui DTN; Nguyen TNN; Hang LTX; Tran TT; Luong BQ
    Sex Health; 2021 Mar; 18(1):104-115. PubMed ID: 33653505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of Risk Perception: Predictors of PrEP Acceptance Among Thai MSM and TG Women at a Community-Based Health Service.
    Plotzker R; Seekaew P; Jantarapakde J; Pengnonyang S; Trachunthong D; Linjongrat D; Janyam S; Nakpor T; Charoenying S; Mills S; Vannakit R; Cassell M; Phanuphak P; Lertpiriyasuwat C; Phanuphak N
    J Acquir Immune Defic Syndr; 2017 Dec; 76(5):473-481. PubMed ID: 28902071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicted Effectiveness of Daily and Nondaily Preexposure Prophylaxis for Men Who Have Sex With Men Based on Sex and Pill-taking Patterns From the Human Immuno Virus Prevention Trials Network 067/ADAPT Study.
    Dimitrov D; Moore JR; Wood D; Mitchell KM; Li M; Hughes JP; Donnell DJ; Mannheimer S; Holtz TH; Grant RM; Boily MC
    Clin Infect Dis; 2020 Jul; 71(2):249-255. PubMed ID: 31437276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engagement in the pre-exposure prophylaxis (PrEP) cascade among a respondent-driven sample of sexually active men who have sex with men and transgender women during early PrEP implementation in Zimbabwe.
    Parmley LE; Harris TG; Chingombe I; Mapingure M; Mugurungi O; Rogers JH; Gozhora P; Wu Y; Samba C; Musuka G; Hakim AJ
    J Int AIDS Soc; 2022 Feb; 25(2):e25873. PubMed ID: 35148029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial.
    Deutsch MB; Glidden DV; Sevelius J; Keatley J; McMahan V; Guanira J; Kallas EG; Chariyalertsak S; Grant RM;
    Lancet HIV; 2015 Dec; 2(12):e512-9. PubMed ID: 26614965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PrEP implementation in the Asia-Pacific region: opportunities, implementation and barriers.
    Zablotska I; Grulich AE; Phanuphak N; Anand T; Janyam S; Poonkasetwattana M; Baggaley R; van Griensven F; Lo YR
    J Int AIDS Soc; 2016; 19(7(Suppl 6)):21119. PubMed ID: 27760688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.